Skip to main content
    G

    GRAIL, LLC (GRAL)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $135.46
    -4.24 (-3.04%)

    Market Cap: $6.24B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    100%(8/8)
    Avg Surprise
    +23.34%
    Streak
    8 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-1.90
    Range$-2.85 - $-1.49
    4 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-2.37+20.0%
    60d ago$-2.38+20.2%
    30d ago$-2.45+22.5%
    7d ago$-2.12+10.5%
    Current$-1.90
    Revenue Consensus
    $44M
    Range$42M - $47M
    10 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-1.23
    Range$-4.09 - $0.35
    5 analysts
    Revenue Consensus
    $55M
    Range$50M - $59M
    11 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.23---
    Sep 26EST
    		-$-1.90---
    Jun 26
    Reported Aug 5
    		$-2.56$-2.91+12.03%Beat+19.5%
    Mar 26
    Reported May 5
    		$-1.37$-1.96+30.10%Beat+55.8%
    Dec 25
    Reported Feb 19
    		$-2.44$-2.53+3.56%Beat+15.6%
    Sep 25
    Reported Nov 12
    		$-2.46$-3.26+24.54%Beat+29.7%
    Jun 25
    Reported Aug 12
    		$-3.18$-3.56+10.67%Beat+93.8%
    Mar 25
    Reported May 13
    		$-3.10$-3.80+18.42%Beat-
    Dec 24
    Reported Feb 20
    		$-2.89$-4.97+41.85%Beat-
    Sep 24
    Reported Nov 12
    		$-3.50$-6.43+45.57%Beat-
    Jun 24
    Reported Aug 13
    		$-51.06N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-15.34EV/EBITDAN/A
    Price/FCF-19.72xFCF Yield-5.07%
    Profitability
    Profit Margin-236.90%Operating Margin-332.00%
    ROE-16.10%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio10.95xQuick Ratio10.74x
    Trading Statistics
    Beta2.84Avg Volume1.50M
    52-Week High$166.4752-Week Low$41.50

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$139.36
    SMA 20$129.67
    SMA 50$97.45
    SMA 200$75.89
    EMA 10$136.01
    EMA 20$127.06
    EMA 50$106.00
    EMA 200$79.04

    MACD

    Line: 12.88Signal: 14.30Hist: -1.42

    ADX

    ADX: 59.1+DI: 39.1-DI: 11.7

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down8.0
    PSAR$158.69

    Bollinger Bands

    Upper Band$162.89
    Lower Band$96.45
    %B Position5124%(Upper)
    Band Width0.59

    RSI (14-Day)

    Neutral
    61.5

    Momentum Oscillators

    Stoch %K41.9
    Stoch %D50.9
    Williams %R-78.1
    ROC (10d)2.2%
    Momentum2.90
    CCI (20d)33.0
    MFI (14d)56.4

    Volatility Measures

    ATR (14d)$9.34(6.9%)
    StdDev (20d)16.61
    Hist Vol144.0%(High)

    Volume Flow

    VWAP$135.68
    OBV-43.5K
    AD Line12.6M
    CMF (20d)0.207

    Volume Metrics

    Avg Vol (20d)1.5M
    Vol Ratio0.5x(Low)
    VWMA (20d)$123.83

    Pivot Points

    R3$149.43
    R2$146.81
    R1$143.25
    Pivot Point$140.63
    S1$137.07
    S2$134.45
    S3$130.89

    Advanced Oscillators

    TSI37.17
    Ultimate Osc52.9
    KST693.69

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$44.69M$40.78M$43.60M$36.19M$35.54M$31.84M$38.25M$28.65M$31.97M$26.72M$30.33M$20.72M
    Cost of Revenue$23.78M$21.62M$21.26M$16.45M$19.85M$18.29M$20.75M$17.41M$16.41M$15.16M$48.98M$14.32M
    Gross Profit$20.91M$19.16M$22.34M$19.74M$15.70M$13.54M$17.50M$11.24M$15.56M$11.56M$-18,650,000$6.40M
    Operating Expenses$194.69M$154.93M$146.75M$145.03M$174.55M$167.15M$154.44M$194.75M$1.66B$238.99M$175.94M$918.79M
    R&D$47.43M$48.02M$46.90M$48.65M$46.63M$53.63M$48.33M$78.23M$94.20M$101.63M$84.09M$80.08M
    SG&A$50.71M$42.77M$38.71M$37.41M$37.91M$45.07M$42.12M$47.42M$67.26M$57.07M$52.73M$50.18M
    Operating Income$-173,783,000$-135,765,000$-124,411,000$-125,291,000$-158,854,000$-153,607,000$-136,938,000$-183,507,000$-1,641,291,000$-227,422,000$-194,593,000$-912,391,000
    Interest Income$7.23M$7.99M$7.96M$6.11M$6.81M$7.78M$9.37M$11.66M$2.81M$2.90M$1.35M$2.53M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-166,708,000$-127,523,000$-116,518,000$-118,718,000$-152,856,000$-146,412,000$-126,994,000$-172,407,000$-1,638,481,000$-224,479,000$-193,029,000$-910,058,000
    Income Tax Expense$-56,461,000$-34,336,000$-17,342,000$-29,741,000$-38,871,000$-40,199,000$-29,928,000$-46,719,000$-53,144,000$-5,565,000$-187,535,000$-18,610,000
    Net Income$-110,247,000$-93,187,000$-99,176,000$-88,977,000$-113,985,000$-106,213,000$-97,066,000$-125,688,000$-1,585,337,000$-218,914,000$-5,494,000$-891,448,000
    EBITDA$-141,463,000$-103,280,000$-90,178,000$-90,638,000$-125,926,000$-121,287,000$-100,086,000$-144,838,000$-1,601,898,000$-187,383,000$-153,100,000$-872,788,000
    EBIT$-173,938,000$-135,509,000$-124,475,000$-124,825,000$-159,665,000$-154,191,000$-136,360,000$-184,068,000$-1,641,286,000$-227,380,000$-193,029,000$-912,587,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GRAL

    News

    Who Is Paying For GRAIL’s Cash Burn?

    GRAIL (GRAL) has consistently burned cash, spending $80 million in the June 2026 quarter, burning 182% of its sales. While its cash reserves of $860 million could last about eleven quarters at the current burn rate...

    Trefis•10/13/26•Somewhat-Bearish

    GRAIL's Chief Growth Officer Andrew Partridge Sells 7,873 Shares to Cover Tax Withholding

    Andrew John Partridge, Chief Growth Officer at GRAIL, Inc. (NASDAQ: GRAL), sold 7,873 common shares on October 5...

    Kalkine Media•10/7/26•Neutral

    To cover vesting taxes, GRAIL (GRAL) CFO Aaron Freidin sells 23,619 shares.

    GRAIL, Inc. Chief Financial Officer Aaron Freidin sold 23,619 common shares on October 5, 2026, at a weighted-average price of $146.39 per share. These shares were automatically sold by a broker in a "sell-to-cover"...

    Stock Titan•10/7/26•Somewhat-Bearish

    This buzzy biotech stock is up 60% this year. Cramer's advice on building a stake

    Jim Cramer discussed Grail (GRAL) stock, noting its 60% year-to-date gain despite a recent dip. He suggests that while Grail has potential, its current valuation makes it speculative...

    CNBC•10/6/26•Somewhat-Bullish

    An officer sold 7,873 shares to cover vesting taxes at GRAIL (NASDAQ: GRAL).

    GRAIL officer Andrew Partridge reported the sale of 7,873 common shares, valued at approximately $1.15 million...

    Stock Titan•10/5/26•Neutral

    GRAL Valuation and Fair Value

    P/E
    -15.3x
    P/FCF
    -19.7x
    P/B
    2.3x
    See GNG's fair value

    GRAL Profitability: Margins, ROIC and FCF

    Gross margin
    49.7%
    Operating margin
    -332.0%
    Net margin
    -236.9%
    ROE
    -16.1%
    FCF margin
    -179.2%
    FCF yield
    -5.1%

    GRAL Competitors

    CompanyTicker
    Iovance Biotherapeutics IncIOVA
    Centessa Pharmaceuticals PLC ADRCNTA
    Lantheus Holdings IncLNTH
    Kiniksa Pharmaceuticals LtdKNSA
    Amneal Pharmaceuticals, Inc. Class A Common StockAMRX
    Rhythm Pharmaceuticals IncRYTM
    Praxis Precision Medicines IncPRAX
    Ligand Pharmaceuticals IncorporatedLGND

    Sector: Healthcare

    GRAL Analyst Ratings

    Consensus
    Hold
    Analysts
    11
    Strong Buy
    0
    Buy
    5
    Hold
    6
    Sell
    0
    Strong Sell
    0

    GRAL Bull Case vs Bear Case

    Bull case

    • GRAL beat EPS estimates in 100.0% of its last 8 reported quarters.
    • GRAL grew quarterly revenue 25.7% year over year.

    Bear case

    • GRAL has a -236.9% net profit margin.

    GRAL Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    23.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-1.90
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About GRAL

    Does GRAL pay dividends?

    GRAIL, LLC (GRAL) does not currently pay a regular dividend.

    What is GRAL's market cap?

    GRAIL, LLC (GRAL) has a market capitalization of $6.24B with a current stock price of $135.46.

    Related stocks

    Sector: Healthcare

    All stocks starting with G

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In